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INTERESTING IMAGEGlomus Tumor of the Neck Detected With
99mTc EDDA HYNIC-TOCNeva Girotto, MD, PhD,* Tatjana Bogović-Crnčić, MD, PhD,*
Svjetlana Grbac-Ivanković, MD, PhD,* and Petra Valković-Zujić, MD, PhD†Abstract: A 54-year-old woman was referred to thyroid evaluation because
of a lump on the left side of the neck. Ultrasound exam did not show any
thyroid abnormality, but highly perfused nodule at the left common carotid
artery bifurcation was found. Because of the specific location, somatostatin
receptor scintigraphy with 99mTc EDDA HYNIC-TOC was performed,
starting with perfusion images and followed with SPECT/CT imaging at 2
and 4 hours. Well-perfused nodule with intensive accumulation and no
other visible pathology in the body raised suspicion of a glomus tumor,
consistent with MR exam performed later. Subsequent surgical removal
confirmed carotid paraganglioma.
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FIGURE 1. Dynamic images (1s/frame) of the neck and upper thoracic region in anterior projection obtained immediately after
intravenous administration of 700 MBq 99mTc EDDA HYNIC-TOC show blood vessels and higher blood flow to the left side of
the neck with emerging focal uptake (black arrow).
Clinical Nuclear Medicine • Volume 42, Number 10, October 2017 Glomus Tumor of the NeckFIGURE 2. The focus was better defined on the blood pool
image (anterior projection, 240s).
FIGURE 3. SPECT/CT scan at 4 hours showing 2 cm nodule at the left common carotid artery bifurcation with intensive 99mTc
EDDA HYNIC-TOC accumulation which was more intense than on the images at 2 hours. “Low-dose” CT showed the exact
location of the nodule which was slightly hypodense. SPECT of the neck/thorax/abdomen region was performed at 2 and
4 hours and fused with “low-dose” CT images of the same regions performed with second SPECT images. Specific location of
well-perfused solitary neck nodule with intensive 99mTc EDDA HYNIC-TOC accumulation and no other visible pathology in the
body raised high suspicion of a glomus tumor.
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FIGURE 4. MRI axial sections in T1-weighted (A) and T1-weighted images after administration of gadolinium (B) at the level of
the supraglottic larynx: lesion sitting (arrow) at the carotid bifurcation with intermediate signal on T1 sequences with intense
and homogenous enhancement after the intravenous administration of gadolinium.
Girotto et al Clinical Nuclear Medicine • Volume 42, Number 10, October 2017FIGURE 5. MRI T2-weighted axial section showing carotid body tumor (A) located between the internal and external carotid
artery displacing internal carotid artery anteriorly. On sagital T2-weighted images, the tumor shows characteristic “salt and
pepper” appearance (B) which represents “signal voids” due to high-velocity flow and resultant signal loss. Finally, surgery was
performed, and histology confirmed carotid body paraganglioma. Carotid body tumors are the most frequent paragangliomas
of the head and neck regions.1–3 Complete surgical resection represents the only curative treatment option,1 although inoperable
and recurrent tumors can be treated with somatostatin analogues.4 Diagnostics of cervical paraganglioma includes Doppler
sonography, MRI combined with contrast-enhanced MR angiography, in specific cases, computed tomography and digital
subtraction angiography. Nuclear medicine diagnostics includes 123I or 131I MIBG (metaiodobenzylguanidine) scintigraphy and
18F-DOPA PET/CT; however, because of the SR content, these tumors can be visualized with somatostatin analogues,
111In-octreotide, and recently, 99mTc EDDA HYNIC–TOC.5–8 In our case, SRS was successfully included in the early phase of
patient workup because of the added value of perfusion images and SPECT/CT hybrid imaging, which revealed high vascularity
and specific location of the lesion, obviating the need for further diagnostic clarification.
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